Pharmacological characterization of a selective agonist for bombesin receptor subtype-3

Biochemical and Biophysical Research Communications

Volumn 387, Issue 2, 2009, Pages 283-288

  Zhang, Li ^a   Nothacker, Hans Peter ^a   Wang, Zhiwei ^a   Bohn, Laura M ^b,c   Civelli, Olivier ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Arrestin; Agonist; Bombesin receptor subtype 3; Calcium mobilization; Receptor trafficking

Indexed keywords

16A; [DEXTRO TYROSINE6 BETA ALANINE11 PHENYLALANINE13 NLE14]BOMBESIN (6-14); BETA ARRESTIN; BOMBESIN; BOMBESIN RECEPTOR; BOMBESIN RECEPTOR 3; BOMBESIN RECEPTOR 3 AGONIST; G PROTEIN COUPLED RECEPTOR; GASTRIN RELEASING PEPTIDE RECEPTOR; LIGAND; NEUROMEDIN B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM MOBILIZATION; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANIMALS; ARRESTINS; CELL MEMBRANE; HUMANS; INDOLES; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PROTEIN TRANSPORT; RATS; RECEPTORS, BOMBESIN;

BOVINE RESPIRATORY SYNCYTIAL VIRUS; MUS;

EID: 67949109456     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.006     Document Type: Article

References (15)

1. Civelli O. GPCR deorphanizations: the novel, the known and the unexpected transmitters. Trends Pharmacol. Sci. 26 (2005) 15-19
2. Fathi Z., Corjay M.H., Shapira H., Wada E., Benya R., Jensen R., Viallet J., Sausville E.A., and Battey J.F. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J. Biol. Chem. 268 (1993) 5979-5984
3. Ohki-Hamazaki H., Watase K., Yamamoto K., Ogura H., Yamano M., Yamada K., Maeno H., Imaki J., Kikuyama S., Wada E., and Wada K. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 390 (1997) 165-169
4. Liu J., Lao Z.J., Zhang J., Schaeffer M.T., Jiang M.M., Guan X.M., Van der Ploeg L.H., and Fong T.M. Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3). Biochemistry 41 (2002) 8954-8960
5. Jennings C.A., Harrison D.C., Maycox P.R., Crook B., Smart D., and Hervieu G.J. The distribution of the orphan bombesin receptor subtype-3 in the rat cns. Neuroscience 120 (2003) 309-324
6. Jensen R.T., Battey J.F., Spindel E.R., and Benya R.V. International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol. Rev. 60 (2008) 1-42
7. Mantey S.A., Weber H.C., Sainz E., Akeson M., Ryan R.R., Pradhan T.K., Searles R.P., Spindel E.R., Battey J.F., Coy D.H., and Jensen R.T. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors. J. Biol. Chem. 272 (1997) 26062-26071
8. Weber D., Berger D., Eichelmann P., Antel J., and Kessler H. Design of selective peptidomimetic agonists for the human orphan receptor BRS-3. J. Med. Chem. 46 (2003) 1918-1930
9. Zhang J., Ferguson S.S., Barak L.S., Aber M.J., Giros B., Lefkowitz R.J., and Caron M.G. Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization. Receptors Channels 5 (1997) 193-199
10. Saito Y., Nothacker H.P., Wang Z., Lin S.H., Leslie F., and Civelli O. Molecular characterization of the melanin-concentrating-hormone receptor. Nature 400 (1999) 265-269
11. Bohn L.M., Dykstra L.A., Lefkowitz R.J., Caron M.G., and Barak L.S. Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. Mol. Pharmacol. 66 (2004) 106-112
12. Laursen S.E., and Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. Pharmacol. Methods 16 (1986) 355-357
13. Kobilka B.K., and Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol. Sci. 28 (2007) 397-406
14. Barak L.S., Wilbanks A.M., and Caron M.G. Constitutive desensitization: a new paradigm for g protein-coupled receptor regulation. Assay Drug Dev. Technol. 1 (2003) 339-346
15. Zhang J., Ferguson S.S., Barak L.S., Bodduluri S.R., Laporte S.A., Law P.Y., and Caron M.G. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc. Natl. Acad. Sci. USA 95 (1998) 7157-7162